Company Filing History:
Years Active: 2006-2017
Title: Christine Anne Louise Watson: Innovator in Pharmaceutical Chemistry
Introduction
Christine Anne Louise Watson is a prominent inventor based in Sandwich, GB. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. Her work focuses on developing innovative compounds that have the potential to address various medical conditions.
Latest Patents
Among her latest patents is the invention titled "Imidazopyridazine derivatives as modulators of the GABAA receptor activity." This invention relates to imidazopyridazine derivatives, specifically 4-(biphenyl-3-yl)-7H-imidazo[4,5-c]pyridazine derivatives. These compounds are designed to modulate the activity of the GABAA receptor and are useful in treating conditions such as pain. Another notable patent is for "Carboxamide derivatives as muscarinic receptor antagonists." This invention encompasses compounds of specific formulas, processes for their preparation, and their use as muscarinic antagonists in pharmaceutical compositions.
Career Highlights
Christine is currently employed at Pfizer Corporation, where she continues to advance her research and development efforts. Her work at Pfizer has allowed her to contribute to the creation of innovative pharmaceutical solutions that can improve patient outcomes.
Collaborations
Throughout her career, Christine has collaborated with notable colleagues, including Paul Alan Glossop and Simon John Mantell. These collaborations have fostered a productive environment for innovation and have led to the successful development of her patented inventions.
Conclusion
Christine Anne Louise Watson is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in medical treatments. Her contributions, particularly in the development of GABAA receptor modulators and muscarinic receptor antagonists, highlight her commitment to improving healthcare through innovation.